Company intelligence / Profile preview
Bell's Healthcare
- Ownership
- Private
- Employees
- ~88
- Development stage
- Other
Overview
Bell’s Healthcare is a long-established UK-based manufacturer of over-the-counter pharmaceuticals with a portfolio of more than 150 product lines and nearly 100 MHRA registered licenses. The company supplies both branded and own-label medicines to wholesalers, supermarkets, pharmacies, and international distributors across more than 65 markets. It maintains high standards of quality assurance with GMP certification and ongoing R&D for new product development. In 2008 it was acquired by Marksans Pharma but continues to operate under its established brand.
- Therapeutic areas
- NeurologyInfectious DiseasesDermatologyGastroenterologyHematologyRheumatology
- Modalities
- Small moleculeNon-pharmacological therapy
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Bell's Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bell's Healthcare.